Stock Comparison
TECH vs VRTX
Bio-Techne Corp and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$11.06B
$124.70B
P/E (TTM)
101.4
29.2
Forward P/E
34.8
25.8
Price/Sales
9.1
10.2
Price/Book
5.3
6.4
EV/EBITDA
43.3
24.0
Dividend Yield
0.45%
—
Profitability
Net Margin
9.05%
35.50%
Operating Margin
25.20%
38.10%
Return on Equity
5.34%
24.20%
Return on Assets
7.45%
12.10%
Growth (YoY)
Revenue Growth
-1.50%
7.80%
Earnings Growth
128.60%
61.40%
Price & Risk
Beta
1.4
0.3
52-Week High
$71.93
$507.92
52-Week Low
$43.12
$362.50
Analyst Target
$65.75
$548.69
Compare TECH and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.